Qingdao Baheal Pharmaceutical Holdings Limited’s Net Profit Rose 39.1% in First Half of 2023

Qingdao Baheal Pharmaceutical Holdings Limited (青岛百洋医药股份有限公司) (301015.SZ) reported a net profit of 292.6 million yuan in the first half of 2023, up 39.1% year-on-year.

Meanwhile, the company posted 3.6 billion yuan in revenue, down 2.6% year-on-year.

At the end of the reporting period, it had 5.4 billion yuan in total assets and 3.1 billion yuan in total liabilities, with a liability-to-asset ratio of 57.4%.